Sodium 4-aminosalicylate (dihydrate)

Sodium 4-aminosalicylate dihydrate (4-Aminosalicylic acid sodium salt dihydrate) is an inhibitor for dihydrofolate reductase (DHFR) and an antituberculous agent. Sodium 4-aminosalicylate dihydrate exhibits anti-inflammatory activity and can be used in research of inflammatory bowel disease (IBD) . Sodium 4-aminosalicylate dihydrate is orally active[1][1][3].

Product Specifications

CAS Number

[6018-19-5]

Product Name Alternative

4-Aminosalicylic acid (sodium salt dihydrate)

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/p-Aminosalicylic-acid-sodium-salt-dihydrate.html

Purity

99.98

Solubility

DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(O[Na])C1=C(O)C=C(N)C=C1.O.O

Molecular Formula

C7H10NNaO5

Molecular Weight

211.15

Precautions

H315, H319, H335

References & Citations

[1]Zheng J, et al. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. J Biol Chem. 2013 Aug 9;288 (32) :23447-56.|[2]Abdu-Allah HHM, et al. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Bioorg Chem. 2020 Jan;94:103378.|[3]Dhaneshwar SS. Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease. World J Gastroenterol. 2014 Apr 7;20 (13) :3564-71.